Swedish company Lignin Industries has introduced a new bio-based thermoplastic elastomer called Renol® TPV, marking its entry into the elastomer materials sector. The product is designed to significantly reduce carbon emissions while maintaining cost competitiveness.
Renol® TPV is formulated with 70% Renol®, a bio-based thermoplastic derived from secondary biomass lignin, and 30% elastomer additives. This composition ensures excellent processability and high-quality end products. By replacing fossil raw materials with renewable biomass, Renol® TPV achieves a groundbreaking 50% reduction in CO2 emissions compared to traditional fossil-based TPV, helping industries meet decarbonization goals.
The granular material integrates seamlessly into existing manufacturing processes, compatible with both recycled and virgin resins, and requires no equipment modifications. Its applications include seals, bellows, protective covers, caps, handles, grips, and impact-absorbing surface infills.
Key advantages include its compatibility with current industrial setups, a potential 50% reduction in CO2 emissions, improved oil resistance, and recyclability. The material can be reprocessed multiple times without losing mechanical properties, thanks to its antioxidant features. Additionally, it offers a competitive price point relative to conventional TPV materials.
As Europe advances policies targeting fossil plastics and CO2 reduction, Renol® TPV offers a scalable and commercially viable solution. Lignin Industries is already testing the material in sectors such as automotive, collaborating with partners like Scania, and exploring applications in industrial equipment and sustainable packaging.
Founded in 2018, Lignin Industries utilizes green chemistry to transform lignin residues from forestry and agriculture into high-performance bio-based plastics. The company’s headquarters is in Knivsta, Sweden, and it aims to reshape the future of sustainable materials.
The post Lignin Industries launches bio-based elastomer to cut CO2 emissions appeared first on World Bio Market Insights.
